United States

Healthcare and Life Sciences: CFOs are leading the path for transformation

From volume to value, compressed margins, and portfolio rationalization, healthcare and life sciences CFOs must navigate this sea of change. Learn how KPMG can assist CFOs and their organizations transform their commercial models, assume appropriate risk, choose likeminded partners, invest in enabling technologies, and apply relevant insights from Big Data. All with an eye to higher patient quality, elevated clinical outcomes, and a profitable and fulfilling future.